Fortitude Family Office’s Maze Therapeutics MAZE Stock Holding History

Fortitude Family Office’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$328	Buy	+11	New	+$288	﹤0.01%	2042

Other funds holding MAZE

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

Fortitude Family Office's MAZE Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Maze Therapeutics (MAZE) in Q2 2026: 11 shares worth $328. The stake represents ﹤0.01% of the portfolio and ranks #2042 among its holdings.

13 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

Fortitude Family Office held 11 shares of Maze Therapeutics worth $328 as of Q2 2026.
Maze Therapeutics was a new Fortitude Family Office position in Q2 2026.
Maze Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2042 holding.
13 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.